They write, "All I can say is wow
doi: 10.1074/mcp.M111.014142 56 ZhuM.ZhuN.SongW
Although the comparison between 34 hr and 58 hr showed no differences in most metabolites except butyrates and OA, we also noticed that some metabolites peaked in 34 hr, while other metabolite kept increasing until 58 hr (cis-aconitate, succinate, nicotinamide (Fig
inadequate essential amino acid availability (particularly leucine) to stimulate MPS
a 1525% historical premium, we think a reasonable amount of GLP-1 risk is already priced in." Consumer Morgan Stanley: Some analysts suggest GLP-1 drugs could reduce calorie intake by 15% to 20%, potentially leading to a 1% to 3% decrease in the nation's calorie consumption by 2030 if 25 to 50 million Americans take the drug
Semaglutide alone carries low hypoglycemia risk in non-diabetic patients